[Do guide lines for differential therapy in hypertrophic obstructive cardiomyopathy exits?].
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D002118:Calcium / Q000037:antagonists & inhibitors; D002312:Cardiomyopathy, Hypertrophic / Q000188:drug therapy*; D004334:Drug Administration Schedule; D006801:Humans; D014700:Verapamil / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D014700:Verapamil; D002118:Calcium
Gibt Richtlinien für eine Differentialtherapie der hypertroph-obstruktiven Kardiomyopathie?